Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| American Osteopathic Association | OTHER |
Not provided
Not provided
Not provided
Not provided
The goal of this observational study is to determine the feasibility of conducting a large-scale study on the effect of using osteopathic manipulative treatment (OMT) to treat patients with post-COVID-19 symptoms. The main questions it aims to answer are:
Participants will receive OMT as directed by their physician and complete questionnaires after every other OMT session.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| osteopathic manipulative treatment (OMT) | Procedure | Osteopathic manipulative treatment provided at the discretion of the treating physician and based on the patient's response to previous treatments. |
| Measure | Description | Time Frame |
|---|---|---|
| Patient recruitment rate (feasibility) | Proportion of patients who enroll in the study out of the number of patients who were eligible for and invited to enroll in the study. | Through study completion, an average of 1 year |
| Data completion rate (feasibility) | Proportions of participants and physicians who complete all their questionnaires. | Through study completion, an average of 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| Neurocognitive and psychological symptoms | Measured using the Rivermead Post Concussion Symptoms Questionnaire | 3 days after every other OMT session for up to 4 months after enrollment and 2 months after the participant's final OMT session |
| Physical symptoms |
| Measure | Description | Time Frame |
|---|---|---|
| Severity of potential adverse events from OMT | Measured by comparing the severity of potential adverse events from OMT during the 3 days following OMT to the severity during the week before OMT. | 3 days after every other OMT session for up to 4 months after enrollment |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients of clinics in the United States where members of the practice-based research network, DO-Touch.NET, practice osteopathic manipulative treatment.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Brian F Degenhardt, DO | A.T. Still University of Health Sciences | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Osteopathic Manipulative Medicine Gutensohn Clinic | Kirksville | Missouri | 63501 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000094024 | Post-Acute COVID-19 Syndrome |
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
Not provided
Not provided
| ID | Term |
|---|---|
| D026301 | Manipulation, Osteopathic |
| ID | Term |
|---|---|
| D026201 | Musculoskeletal Manipulations |
| D000529 | Complementary Therapies |
| D013812 | Therapeutics |
| D026741 | Physical Therapy Modalities |
Not provided
Not provided
Not provided
Not provided
Not provided
Measured using the Long COVID-Household Pulse Survey |
| 3 days after every other OMT session for up to 4 months after enrollment and 2 months after the participant's final OMT session |
| Global health | Measured using the PROMIS SF v1.2 Global Health scale | 3 days after every other OMT session for up to 4 months after enrollment and 2 months after the participant's final OMT session |
| Return to work | For participants who were employed prior to COVID-19, their current working status will be assessed on a 4-point scale (1. returned to full-time work without restrictions, 2. returned to full-time work but with modified job duties, 3) returned to work but with reduced working hours, 4. have not been able to return to work. | 3 days after every other OMT session for up to 4 months after enrollment and 2 months after the participant's final OMT session |
| D007239 |
| Infections |
| D014777 | Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D000094025 | Post-Infectious Disorders |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012046 | Rehabilitation |